Speaker illustration

Miss Hayang Yang

Academic Medical Centre, Amsterdam (Netherlands (The))

Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Drug therapy in congenital heart disease - What are the options and the needs?

Thumbnail

High rate of thromboembolism in adults with congenital heart disease with atrial arrhythmias under traditional management of thromboembolic prevention

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Risk prediction

Thumbnail

Atrial arrhythmias are not associated with stroke in adults with congenital heart disease under current anticoagulation treatment

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Thumbnail

Adults with congenital heart disease and supraventricular tachyarrhythmia are at high risk for stroke and death

Event: ESC Congress 2016

Topic: GUCH and paediatric cardiology, others

Session: Congenital heart disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb